These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 3834585)

  • 1. Generalized phospholipidosis induced by an amphiphilic cationic psychotropic drug.
    Robison RL; Visscher GE; Roberts SA; Engstrom RG; Hartman HA; Ballard FH
    Toxicol Pathol; 1985; 13(4):335-48. PubMed ID: 3834585
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhaled cationic amphiphilic drug-induced pulmonary phospholipidosis in rats and dogs: time-course and dose-response of biomarkers of exposure and effect.
    Pauluhn J
    Toxicology; 2005 Feb; 207(1):59-72. PubMed ID: 15590122
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of physicochemical calculation of pKa and CLogP to predict phospholipidosis-inducing potential: a case study with structurally related piperazines.
    Ploemen JP; Kelder J; Hafmans T; van de Sandt H; van Burgsteden JA; Saleminki PJ; van Esch E
    Exp Toxicol Pathol; 2004 Mar; 55(5):347-55. PubMed ID: 15088636
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cationic amphiphilic drug-induced phospholipidosis.
    Halliwell WH
    Toxicol Pathol; 1997; 25(1):53-60. PubMed ID: 9061852
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drug-induced phospholipidosis. I. Lipid composition and chlorphentermine content of rat lung tissue and alveolar macrophages after chronic treatment.
    Schmien R; Seiler KU; Wassermann O
    Naunyn Schmiedebergs Arch Pharmacol; 1974; 283(3):331-4. PubMed ID: 4276759
    [No Abstract]   [Full Text] [Related]  

  • 6. Phospholipidosis in rats treated with amiodarone: serum biochemistry and whole genome micro-array analysis supporting the lipid traffic jam hypothesis and the subsequent rise of the biomarker BMP.
    Mesens N; Desmidt M; Verheyen GR; Starckx S; Damsch S; De Vries R; Verhemeldonck M; Van Gompel J; Lampo A; Lammens L
    Toxicol Pathol; 2012 Apr; 40(3):491-503. PubMed ID: 22291062
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drug-induced phospholipidosis: are there functional consequences?
    Reasor MJ; Kacew S
    Exp Biol Med (Maywood); 2001 Oct; 226(9):825-30. PubMed ID: 11568304
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vivo and in vitro reversibility of chlorphentermine-induced phospholipidosis in rat alveolar macrophages.
    McCloud CM; Beard TL; Kacew S; Reasor MJ
    Exp Mol Pathol; 1995 Feb; 62(1):12-21. PubMed ID: 7556587
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drug-induced phospholipidosis.
    Lüllmann H; Lüllmann-Rauch R; Wassermann O
    Ger Med; 1973; 3(3-4):128-35. PubMed ID: 4370610
    [No Abstract]   [Full Text] [Related]  

  • 10. Immunohistochemistry of LAMP-2 and adipophilin for phospholipidosis in liver and kidney in ketoconazole-treated mice.
    Asaoka Y; Togashi Y; Imura N; Sai T; Miyoshi T; Miyamoto Y
    Exp Toxicol Pathol; 2013 Sep; 65(6):817-23. PubMed ID: 23276623
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vivo toxicity and pulmonary effects of promazine and chlorpromazine in rats.
    Kodavanti UP; Lockard VG; Mehendale HM
    J Biochem Toxicol; 1990; 5(4):245-51. PubMed ID: 1965728
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chlorcyclizine--induced pulmonary phospholipidosis in rats.
    Reasor MJ; Heyneman CA; Walker ER
    Res Commun Chem Pathol Pharmacol; 1982 Nov; 38(2):235-46. PubMed ID: 6131507
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Morphological, histochemical and biochemical changes induced by homochlorcyclizine in the rat].
    Lageron A; Saffroy M
    Acta Histochem; 1982; 71(1):103-10. PubMed ID: 6128854
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drug-induced phospholipidosis.
    Anderson N; Borlak J
    FEBS Lett; 2006 Oct; 580(23):5533-40. PubMed ID: 16979167
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antidepressant-induced lipidosis with special reference to tricyclic compounds.
    Xia Z; Ying G; Hansson AL; Karlsson H; Xie Y; Bergstrand A; DePierre JW; Nässberger L
    Prog Neurobiol; 2000 Apr; 60(6):501-12. PubMed ID: 10739086
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Experimental phospholipidosis induced by 4,4'-diethyl-aminoethoxyhexestrol. Morphological and biochemical interpretations.
    Tashiro Y; Watanabe Y; Enomoto Y
    Acta Pathol Jpn; 1983 Sep; 33(5):929-42. PubMed ID: 6316720
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Amiodarone induced phospholipidosis. Biochemical, morphological and functional changes in the lungs of rats chronically treated with amiodarone.
    Riva E; Marchi S; Pesenti A; Bizzi A; Cini M; Veneroni E; Tavbani E; Boeri R; Bertani T; Latini R
    Biochem Pharmacol; 1987 Oct; 36(19):3209-14. PubMed ID: 3663236
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A toxicogenomic approach to drug-induced phospholipidosis: analysis of its induction mechanism and establishment of a novel in vitro screening system.
    Sawada H; Takami K; Asahi S
    Toxicol Sci; 2005 Feb; 83(2):282-92. PubMed ID: 15342952
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phospholipidosis effect of drugs by adsorption into lipid monolayers.
    Ceccarelli M; Germani R; Massari S; Petit C; Nurisso A; Wolfender JL; Goracci L
    Colloids Surf B Biointerfaces; 2015 Dec; 136():175-84. PubMed ID: 26387069
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytochemical demonstration of increased phospholipid content in cell membranes in chlorphentermine-induced phospholipidosis.
    Coulombe PA; Bendayan M
    J Histochem Cytochem; 1989 Feb; 37(2):139-47. PubMed ID: 2911004
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.